{"id":"https://openalex.org/W4387842887","doi":"https://doi.org/10.1016/j.biopha.2023.115712","title":"Prolonged release pirfenidone pharmacokinetics is modified in cirrhosis GENESIS study","display_name":"Prolonged release pirfenidone pharmacokinetics is modified in cirrhosis GENESIS study","publication_year":2023,"publication_date":"2023-10-21","ids":{"openalex":"https://openalex.org/W4387842887","doi":"https://doi.org/10.1016/j.biopha.2023.115712","pmid":"https://pubmed.ncbi.nlm.nih.gov/37871556"},"language":"en","primary_location":{"id":"doi:10.1016/j.biopha.2023.115712","doi":"https://doi.org/10.1016/j.biopha.2023.115712","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.biopha.2023.115712","pdf_url":null,"source":{"id":"https://openalex.org/S15111687","display_name":"Biomedicine & Pharmacotherapy","issn_l":"0753-3322","issn":["0753-3322","1950-6007"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-2","ki-jl-1","medline","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedicine & Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1016/j.biopha.2023.115712","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024763540","display_name":"Jorge Luis Poo","orcid":"https://orcid.org/0000-0001-8205-5379","observed_orcids":["https://orcid.org/0000-0001-8205-5379"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Jorge L. Poo","raw_affiliation_strings":["Grupo Mexicano para el Estudio de las Enfermedades Hep\u00e1ticas, Mexico. Electronic address: consultorio.jpoo@gmail.com","Grupo Mexicano para el Estudio de las Enfermedades Hep\u00e1ticas, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo Mexicano para el Estudio de las Enfermedades Hep\u00e1ticas, Mexico. Electronic address: consultorio.jpoo@gmail.com","institution_ids":[]},{"raw_affiliation_string":"Grupo Mexicano para el Estudio de las Enfermedades Hep\u00e1ticas, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Juan R. Aguilar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Juan R. Aguilar","raw_affiliation_strings":["Grupo Mexicano para el Estudio de las Enfermedades Hep\u00e1ticas, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo Mexicano para el Estudio de las Enfermedades Hep\u00e1ticas, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000143027","display_name":"Ra\u00fal Bernal-Reyes","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Raul Bernal-Reyes","raw_affiliation_strings":["Sociedad Espa\u00f1ola de Beneficencia, Pachuca, Hidalgo, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sociedad Espa\u00f1ola de Beneficencia, Pachuca, Hidalgo, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111650333","display_name":"Rosalba Alonso-Campero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210104806","display_name":"Mexican Association for the Clinical Research","ror":"https://ror.org/01f233332","country_code":"MX","type":"facility","lineage":["https://openalex.org/I4210104806"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Rosalba Alonso-Campero","raw_affiliation_strings":["AMIC Clinical Research Center Pachuca Hidalgo, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AMIC Clinical Research Center Pachuca Hidalgo, Mexico","institution_ids":["https://openalex.org/I4210104806"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094102069","display_name":"Frida Gasca\u2010D\u00edaz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Frida Gasca","raw_affiliation_strings":["Grupo Mexicano para el Estudio de las Enfermedades Hep\u00e1ticas, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo Mexicano para el Estudio de las Enfermedades Hep\u00e1ticas, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001815241","display_name":"Larissa Hern\u00e1ndez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Larissa Hern\u00e1ndez","raw_affiliation_strings":["Grupo Mexicano para el Estudio de las Enfermedades Hep\u00e1ticas, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo Mexicano para el Estudio de las Enfermedades Hep\u00e1ticas, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042274573","display_name":"Everardo Pi\u00f1eyro-Garza","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Everardo Pineyro-Garza","raw_affiliation_strings":["Ipharma Pharmacology Unit Monterrey Nuevo Le\u00f3n, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ipharma Pharmacology Unit Monterrey Nuevo Le\u00f3n, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065976770","display_name":"Magdalena G\u00f3mez\u2010Silva","orcid":"https://orcid.org/0000-0001-8169-2253","observed_orcids":["https://orcid.org/0000-0001-8169-2253"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Magdalena Gomez-Silva","raw_affiliation_strings":["Ipharma Pharmacology Unit Monterrey Nuevo Le\u00f3n, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ipharma Pharmacology Unit Monterrey Nuevo Le\u00f3n, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010361356","display_name":"Mar\u00eda Elena Gamino-Pe\u00f1a","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Elena Gamino","raw_affiliation_strings":["Ipharma Pharmacology Unit Monterrey Nuevo Le\u00f3n, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ipharma Pharmacology Unit Monterrey Nuevo Le\u00f3n, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025142072","display_name":"Mario Gonz\u00e1lez-de la Parra","orcid":"https://orcid.org/0000-0003-1349-8955","observed_orcids":["https://orcid.org/0000-0003-1349-8955"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mario Gonz\u00e1lez-de la Parra","raw_affiliation_strings":["Biokinetics, Ciudad de Mexico, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biokinetics, Ciudad de Mexico, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Pedro Pe\u00f1a","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pedro Pe\u00f1a","raw_affiliation_strings":["Grupo Medipharma, Ciudad de Mexico,, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo Medipharma, Ciudad de Mexico,, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102570288","display_name":"Nadiel Hern\u00e1ndez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nadiel Hern\u00e1ndez","raw_affiliation_strings":["Grupo Medipharma, Ciudad de Mexico,, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo Medipharma, Ciudad de Mexico,, Mexico","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073120397","display_name":"Graciela Tapia","orcid":"https://orcid.org/0000-0002-3181-8441","observed_orcids":["https://orcid.org/0000-0002-3181-8441"]},"institutions":[{"id":"https://openalex.org/I8961855","display_name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico","ror":"https://ror.org/01tmp8f25","country_code":"MX","type":"education","lineage":["https://openalex.org/I8961855"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Graciela Tapia","raw_affiliation_strings":["Departmento de Gen\u00e9tica y Bioestad\u00edstica, Universidad Nacional Aut\u00f3noma de Mexico, Mexico"],"raw_orcid":"https://orcid.org/0000-0002-3181-8441","affiliations":[{"raw_affiliation_string":"Departmento de Gen\u00e9tica y Bioestad\u00edstica, Universidad Nacional Aut\u00f3noma de Mexico, Mexico","institution_ids":["https://openalex.org/I8961855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013743804","display_name":"Linda Elsa Mu\u00f1oz-Espinosa","orcid":"https://orcid.org/0000-0002-0455-9325","observed_orcids":["https://orcid.org/0000-0002-0455-9325"]},"institutions":[{"id":"https://openalex.org/I169046204","display_name":"Universidad Aut\u00f3noma de Nuevo Le\u00f3n","ror":"https://ror.org/01fh86n78","country_code":"MX","type":"education","lineage":["https://openalex.org/I169046204"]}],"countries":["MX"],"is_corresponding":false,"raw_author_name":"Linda E. Mu\u00f1oz-Espinosa","raw_affiliation_strings":["Grupo Mexicano para el Estudio de las Enfermedades Hep\u00e1ticas, Mexico; Hospital Universitario, Universidad Aut\u00f3noma de Nuevo Le\u00f3n, Monterrey, Mexico","Grupo Mexicano para el Estudio de las Enfermedades Hep\u00e1ticas, Mexico","Hospital Universitario, Universidad Aut\u00f3noma de Nuevo Le\u00f3n, Monterrey, Mexico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo Mexicano para el Estudio de las Enfermedades Hep\u00e1ticas, Mexico; Hospital Universitario, Universidad Aut\u00f3noma de Nuevo Le\u00f3n, Monterrey, Mexico","institution_ids":["https://openalex.org/I169046204"]},{"raw_affiliation_string":"Grupo Mexicano para el Estudio de las Enfermedades Hep\u00e1ticas, Mexico","institution_ids":[]},{"raw_affiliation_string":"Hospital Universitario, Universidad Aut\u00f3noma de Nuevo Le\u00f3n, Monterrey, Mexico","institution_ids":["https://openalex.org/I169046204"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5024763540"],"corresponding_institution_ids":[],"apc_list":{"value":3050,"currency":"USD","value_usd":3050},"apc_paid":{"value":3050,"currency":"USD","value_usd":3050},"fwci":2.3602,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.87910507,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"168","issue":null,"first_page":"115712","last_page":"115712"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.24240000545978546,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.24240000545978546,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10337","display_name":"Liver Disease and Transplantation","score":0.19020000100135803,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.0828000009059906,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pirfenidone","display_name":"pirfenidone","score":1.0},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.843999981880188},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9079999923706055},{"id":"https://openalex.org/keywords/liver-cirrhosis","display_name":"liver cirrhosis","score":0.9789999723434448},{"id":"https://openalex.org/keywords/liver-dysfunction","display_name":"liver dysfunction","score":0.8550000190734863},{"id":"https://openalex.org/keywords/child-pugh-score","display_name":"Child-Pugh score","score":0.8199999928474426},{"id":"https://openalex.org/keywords/hepatic-drug-metabolism","display_name":"hepatic drug metabolism","score":0.6399999856948853},{"id":"https://openalex.org/keywords/plasma-exposure","display_name":"plasma exposure","score":0.6039999723434448}],"concepts":[{"id":"https://openalex.org/C2777214474","wikidata":"https://www.wikidata.org/wiki/Q147778","display_name":"Cirrhosis","level":2,"score":0.8971469402313232},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8569934368133545},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.7825477123260498},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7819942235946655},{"id":"https://openalex.org/C2779832356","wikidata":"https://www.wikidata.org/wiki/Q2060696","display_name":"Pirfenidone","level":4,"score":0.7512149214744568},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5972918272018433},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5562126636505127},{"id":"https://openalex.org/C2777075537","wikidata":"https://www.wikidata.org/wiki/Q929737","display_name":"Liver disease","level":2,"score":0.49755099415779114},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4821900427341461},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3454849421977997},{"id":"https://openalex.org/C2778341716","wikidata":"https://www.wikidata.org/wiki/Q2290446","display_name":"Idiopathic pulmonary fibrosis","level":3,"score":0.21605870127677917},{"id":"https://openalex.org/C2777714996","wikidata":"https://www.wikidata.org/wiki/Q7886","display_name":"Lung","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008103","descriptor_name":"Liver Cirrhosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008107","descriptor_name":"Liver Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011728","descriptor_name":"Pyridones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.biopha.2023.115712","doi":"https://doi.org/10.1016/j.biopha.2023.115712","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.biopha.2023.115712","pdf_url":null,"source":{"id":"https://openalex.org/S15111687","display_name":"Biomedicine & Pharmacotherapy","issn_l":"0753-3322","issn":["0753-3322","1950-6007"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-2","ki-jl-1","medline","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedicine & Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:37871556","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37871556","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","raw_type":"Journal Article"},{"id":"doi:10.60692/e8wbm-bgc83","doi":"https://doi.org/10.60692/e8wbm-bgc83","is_oa":true,"landing_page_url":"https://doi.org/10.60692/e8wbm-bgc83","pdf_url":null,"source":{"id":"https://openalex.org/S7407051682","display_name":"Greater South Information System","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},{"id":"doi:10.60692/jjcgf-azx59","doi":"https://doi.org/10.60692/jjcgf-azx59","is_oa":true,"landing_page_url":"https://doi.org/10.60692/jjcgf-azx59","pdf_url":null,"source":{"id":"https://openalex.org/S7407051682","display_name":"Greater South Information System","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.1016/j.biopha.2023.115712","doi":"https://doi.org/10.1016/j.biopha.2023.115712","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.biopha.2023.115712","pdf_url":null,"source":{"id":"https://openalex.org/S15111687","display_name":"Biomedicine & Pharmacotherapy","issn_l":"0753-3322","issn":["0753-3322","1950-6007"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-2","ki-jl-1","medline","poland-100","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Biomedicine & Pharmacotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":20,"referenced_works":["https://openalex.org/W1511559120","https://openalex.org/W1789181350","https://openalex.org/W1892866382","https://openalex.org/W1985120408","https://openalex.org/W2072861622","https://openalex.org/W2116870650","https://openalex.org/W2157429545","https://openalex.org/W2210675832","https://openalex.org/W2513169538","https://openalex.org/W2992545769","https://openalex.org/W3002376302","https://openalex.org/W3068631629","https://openalex.org/W3120511139","https://openalex.org/W4211124708","https://openalex.org/W4213444447","https://openalex.org/W4225282432","https://openalex.org/W4285087410","https://openalex.org/W4294677238","https://openalex.org/W4297906266","https://openalex.org/W4310776655"],"related_works":["https://openalex.org/W2522175177","https://openalex.org/W7099231273","https://openalex.org/W4392605477","https://openalex.org/W4410590470","https://openalex.org/W2044877748","https://openalex.org/W2155681713","https://openalex.org/W3068631629","https://openalex.org/W2157848623","https://openalex.org/W2131053555","https://openalex.org/W2029697279"],"abstract_inverted_index":{"In":[0,54],"both":[1],"clinical":[2,112,221],"and":[3,10,52,71,79,108,149,157,165,169,177],"experimental":[4],"trials,":[5],"pirfenidone":[6,106],"(PFD)":[7],"showed":[8],"anti-inflammatory":[9],"antifibrogenic":[11],"effects.":[12],"Considering":[13],"the":[14,31,111,188],"wide":[15],"variation":[16],"in":[17,21,41,110,152,161,172,180,204,211,220],"hepatic":[18],"functional":[19],"reserve":[20],"patients":[22,181,205],"with":[23,59,65,73,154,174,206,209],"cirrhosis,":[24,164,183],"we":[25],"decided":[26],"to":[27,138,145],"learn":[28],"more":[29],"about":[30],"pharmacokinetics":[32],"of":[33,37,83,101,105,199],"a":[34,80,102],"new":[35],"formulation":[36,104],"prolonged":[38],"release":[39],"PFD":[40,140,192],"this":[42,55],"population":[43],"(PR-PFD),":[44],"focusing":[45],"on":[46,49],"assessing":[47],"changes":[48],"AUC0\u2013\u221e,":[50],"AUC0\u2013t,":[51],"Cmax.":[53],"study,":[56],"24":[57],"subjects":[58,64,86,153,162,173],"cirrhosis":[60,207],"were":[61,91,123],"included:":[62],"eight":[63,72,84],"mild":[66],"liver":[67,75,215],"impairment":[68,76,216],"(Child\u2013Pugh":[69,77],"A)":[70],"moderate":[74],"B),":[78],"third":[81],"group":[82],"age-matched":[85],"without":[87,163,182,184],"fibrosis.":[88],"All":[89],"participants":[90],"under":[92],"fasting":[93],"conditions":[94],"before":[95],"receiving":[96],"orally":[97],"two":[98,189],"600-mg":[99],"tablets":[100],"prolonged-release":[103],"(PR-PFD)":[107],"remained":[109],"unit":[113],"for":[114],"36":[115],"h":[116],"after":[117,125],"PR-PFD":[118,146,200],"administration.":[119],"Serial":[120],"blood":[121],"samples":[122],"collected":[124],"dosing":[126],"(0.5-36":[127],"h).":[128],"A":[129,156],"validated":[130],"high-performance":[131],"liquid":[132],"chromatography\u2013mass":[133],"spectrometry":[134],"method":[135],"was":[136,147,167,193],"used":[137],"determine":[139],"plasma":[141],"concentrations.":[142],"The":[143,196],"exposure":[144],"3.6-":[148],"4.4-fold":[150],"greater":[151,171],"Child\u2013Pugh":[155,158,175],"B":[159,176],"than":[160,179],"Cmax":[166],"1.6-":[168],"1.8-fold":[170],"Child\u2013Pugh-A":[178],"significant":[185],"differences":[186],"between":[187],"cirrhotic":[190],"groups.":[191],"well":[194],"tolerated.":[195],"pharmacokinetic":[197],"parameters":[198],"are":[201],"significantly":[202],"modified":[203],"compared":[208],"those":[210],"controls,":[212],"indicating":[213],"that":[214],"should":[217],"be":[218],"considered":[219],"practice.":[222]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2023-10-22T00:00:00"}